Jenthera Therapeutics is a preclinical gene editing company developing a novel direct protein delivery CRISPR platform towards the development of groundbreaking therapeutics in oncology. Through a biologic-oriented approach, our platform resolves the greatest unmet need in gene editing: cellular delivery. Current systems use viruses, liposomes or nanoparticles to shuttle the CRISPR nuclease to cells, severely limiting the range of possible targets, creating off-target and immune responses and bearing complex manufacturing. Our uniquely differentiated platform circumvents these limitations through the direct delivery of the CRISPR protein while achieving unprecedented precision, exquisite tailoring for a largely extended range of tissue and cell targets, safety from off-target and immune responses and simple manufacturing. Solid data from our two internal programs supports the potential of our platform for transformative, personalized and accessible in-vivo therapies. Our lead program unlocks a new frontier in CAR-T developments leveraging our platform’s high frequencies of homology-directed repair to deliver CAR insertions in-vivo in the context of B-cell lymphoma. Our second internal program targets an undruggable and highly prized oncology target, KRAS in the context of non-small cell lung cancer and represents the first systemically administered ribonucleoprotein CRISPR system achieving targeted delivery to a solid tumor. In both our CAR-T and KRAS programs, the complete eradication of the targeted tumors was observed at low doses. Other programs are being currently pursued along with partners. The versatility and highly advanced capabilities of our platform allow for the establishment of partnerships based on our partner’s target of choice. We are currently seeking investors for our Series A raise and partners with whom we can shape the next generation of gene editing therapeutics and define curative solutions for society’s greatest health challenges. | x
Jefo Nutrition Inc
Jefo is a global leader in high-performance non-medicated nutritional solutions for animals. Founded in 1982 in Canada, Jefo markets its species-specific products in close to 80 countries with offices worldwide. To be the preferred supplier for those striving to reduce or eliminate the use of antibiotics in their production systems, Jefo invests in innovation and development. With its Life, made easier commitment in mind, Jefo uses a practical approach to share its results based on complex scientific research and testing methods. Jefo aims to improve animal health and increase human longevity by feeding growing populations with better protein sources, coming from systems that respect an animal’s welfare and use natural solutions to reduce the use of medicines. In order to do so, it produces species-specific protected formulas with the innovative Jefo Matrix Technology, which takes into account the digestive transit time of each species to enable a targeted release of nutrients in the intestines. The company proposes various solutions such as essential oils, acidifiers, enzymes, amino acids, vitamins, minerals and bypass fats, which are divided in three programs: Jefo Care – Prevention & Health, Jefo Peak – Performance & Production, and Jefo Cycle – Reproduction.
Jardins Cousineau
Our family business, Les Jardins Paul Cousineau & fils inc., is the leading broccoli producer in Canada. Being environmentally responsible is a core value for us, and we understand how important local sourcing is, both to benefit Quebec producers and to minimize our environmental footprint. Taking advantage of the latest technology, our innovative business stands out because of our production capacity and commitment to clients.
Ivys Adsorption
At Ivys Adsorption, we distribute products for compressed air, including Elgi compressors, KSI air dryers, gas dryers, compressor filters and parts, and industrial desiccants. We also service, maintain and repair all brands of industrial air compressors. The Elgi compressor range includes oil-free compressors, rotary screw compressors, portable air compressors, and variable speed air compressors. These compressors are known for their energy efficiency, reliability, and an industry-leading warranty. Ivys offers a full range of air compression products for one-stop shopping, with proven quality and rapid delivery of parts. Our team has decades of experience in the compressed air industry. Our technical support team delivers exception support. They are fully-trained and offer expert advice to ensure the right solution with right products for your application. Our dedicate customer service team is always ready to help. | Ivys designs, manufactures, and supports high-performance, innovative pressure swing adsorption (PSA) systems for hydrogen separation and purification, achieving 99.9999% purity and up to a 95% recovery. Due to their innovative fast-cycle rotary valve design and advanced adsorbents, Ivys’ PSAs are the most compact, cost-effective, and reliable systems available today. These systems have been field-tested across diverse applications. Systems are skid-mounted, simple to operate with one control signal, and availability is typically greater than 99.5 %. Operating cost is low as power consumption is usually less than 1 kW. The application includes on-site H2 generation via SMR syngas for vehicle refueling (HRS), distributed H2 generation via SMR for HRS and industrial use (H2 Hub), renewable H2 generation via gasification, pyrolysis, or biological processes, H2 purification from ammonia cracking gas, H2 recovery from industrial process gases, CO2 capture from combustion flue gas and process gases.
ITR Laboratories Canada Inc
Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 30 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with over 400 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. ITR is committed to providing the highest quality services to suit the needs of sponsors; our expert staff will continue to stay up-to-date with the latest technological developments to ensure we are always ready for new and challenging projects. | Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. We also offer juvenile toxicology services. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 30 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with nearly 500 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. ITR is committed to providing the highest quality services to suit the needs of sponsors; our expert staff will continue to stay up-to-date with the latest technological developments to ensure we are always ready for new and challenging projects. | Located in Montreal, Canada, ITR Laboratories is a full service CRO offering nonclinical toxicology testing for developing drugs. ITR’s GLP-compliant safety testing services can support your next product registration effort in any global market. We perform studies in general toxicology, inhalation, infusion, safety pharmacology, immunology and genetic toxicology. We also offer juvenile toxicology services. Lab support services include analytical, bioanalytical, ligand binding (PK, PD and biomarkers) assays, and flow cytometry. Over 35 years, ITR has grown from a small facility with 50 staff, to a mid-sized CRO with over 500 employees serving the global market. With over 6000 studies successfully completed, ITR continues to expand its facility and the expertise of its scientific staff. Our most recent expansion was completed in February of 2023 and added an additional 8 animal rooms for a total of 80 rooms. Specializing in inhalation toxicology, ITR has 22 exposure rooms with over 750 completed inhalation studies, ITR is ranked as the #1 inhalation CRO in the world. ITR is committed to providing the highest quality services tailored to the needs of sponsors; our expert staff continues to stay up-to-date with the latest technological developments to ensure readiness for new and challenging projects.
ISAAC
Workflow Platform for AV Systems ISAAC helps you access, operate, and maintain AV systems all from a web browser.
IPL
PL is a leading North American manufacturer of injection-molded plastic products partnering with customers to deliver sustainable solutions to the food, retail, industrial, agricultural, material handling, and environmental end-markets. With our expertise in plastics and impressive production capacity, you get the results you demand, and a steady supply of products, even on the most complex projects. We have been your packaging experts since 1939, from our wide range of solutions to our custom product development, we act at every step to support your productivity and competitiveness.
Investissement Quebec International
Québec is one of North America’s most dynamic hubs for life sciences and health technologies, with more than 750 companies and 40,000 highly skilled professionals across the full innovation value chain. The province offers world-class research infrastructure, a strong network of contract research organizations, and recognized expertise in areas such as precision medicine, genomics, vaccines, RNA technologies, and cell and gene therapies. A robust clinical research environment—supported by leading university hospitals, efficient regulatory timelines, and a diverse patient population—enables companies to accelerate development and commercialization. Montréal is also a global leader in artificial intelligence applied to healthcare, strengthening Québec’s innovation capacity. Investissement Québec International supports Québec companies in expanding globally by connecting them with international partners, clients, and collaborators. At BIO 2026, our delegation is looking to build new business relationships and explore partnership opportunities with organizations across the life sciences sector. | The government corporation dedicated to Québec’s economic development Investissement Québec’s mission is to play an active role in Québec’s economic development by spurring business innovation, entrepreneurship and business acquisitions, as well as growth in investment and exports. Working through Investissement Québec International, the Corporation: Supports Québec businesses with their export projects, and Prospects for foreign talent and investment.